Insider Transactions in Q3 2024 at Idexx Laboratories Inc (IDXX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2024
|
Jonathan W Ayers Director |
BUY
Bona fide gift
|
Indirect |
532,179
+48.94%
|
-
|
|
Sep 06
2024
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Indirect |
302,179
-100.0%
|
-
|
|
Sep 06
2024
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
230,000
-86.58%
|
-
|
|
Sep 06
2024
|
M Anne Szostak Director |
SELL
Open market or private sale
|
Indirect |
500
-100.0%
|
$234,500
$469.37 P/Share
|
|
Sep 05
2024
|
M Anne Szostak Director |
BUY
Bona fide gift
|
Indirect |
500
+50.0%
|
-
|
|
Sep 05
2024
|
M Anne Szostak Director |
SELL
Bona fide gift
|
Indirect |
500
-7.62%
|
-
|
|
Sep 01
2024
|
Michael Schreck Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
48
-4.99%
|
$23,088
$481.33 P/Share
|
|
Sep 01
2024
|
Michael Schreck Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
164
+14.58%
|
-
|
|
Sep 01
2024
|
Martin Alexander Smith Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
5
-0.97%
|
$2,405
$481.33 P/Share
|
|
Sep 01
2024
|
Martin Alexander Smith Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
18
+3.38%
|
-
|
|
Aug 05
2024
|
Jonathan Jay Mazelsky President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
170
-0.21%
|
$77,350
$455.08 P/Share
|
|
Aug 05
2024
|
Jonathan Jay Mazelsky President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
384
+0.47%
|
-
|
|
Aug 05
2024
|
Brian P Mckeon EVP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
117
-0.38%
|
$53,235
$455.08 P/Share
|
|
Aug 05
2024
|
Brian P Mckeon EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
192
+0.61%
|
-
|